PPD™ Vestrum Health™ Real-World Data

Our Solutions Clinical Development Proprietary Real-World Data PPD Vestrum Health Real-World Data

Advancing your research with insightful, patient-level clinical retina data

Electronic health records (EHRs) provide a wealth of real-world patient data that are extremely useful in the research and development of medical interventions. Compared with alternative data sources and study approaches, such as cohort studies or randomized controlled trials, the use of routinely collected data offers several advantages, including lower administrative efforts and costs, reduced sample size bias due to larger sample sizes, and the benefit of revising analyses over time as new data become available.

There are, however, methodological challenges associated with the use of EHR for research analyses, due to a lack of outcomes and biomarker data in standard EHR data. Advance your research and gain confidence in the results by engaging a partner who has in-depth data expertise and is well-versed in EHR evaluation and use.

Explore using EHR data.

PPD™ Vestrum Health™ Real-World Data

Accelerating patient access to retinal interventions

Accurately capture, analyze and understand real-world clinical behaviors and the decisions of those impacted by retinal treatments and diseases like diabetic retinopathy, diabetic macular edema and wet macular degeneration. Assess real-time market trends alongside patient characteristics and outcomes occurring in the retina space with PPD™ Vestrum Health™ Real-World Data, our unique and proprietary retina U.S. EHR dataset. Design studies that can assess demographic, clinical and anatomic profiles of patients seen in the real world, including retrospective and de-identified retina data with deep clinical abilities vetted by practicing retinal specialists.

Gain insights into a wide range of research questions, allowing you to:

Provide real-world evidence of product efficacy and durability
Provide a national or regional view into disease incidence, prevalence and unmet need
Evaluate the market landscape and competitor activity through treatment regimen, switching behavior and dosing interval
Evaluate insurers’ influence on driving market decisions
Understand your market share and incorporate other analytics
Answer clinical research questions regarding treatment effectiveness, disease incidence or prevalence, treatment behavior and associated outcomes

Optimize the value of retinal EHR data with advanced scientific methods provided by a team of innovative database design and operations experts specializing in retinal conditions. With deep roots in health care analytics, our retina team has more than 10 years of experience extracting EHR details, leveraging proprietary processes and algorithms to allow the automated extraction of important EHR data.

It has been a great pleasure partnering with you on multiple projects! Your data on U.S. retina patients is high-quality, and your highly knowledgeable analytics team is a great thought partner, in addition to providing excellent quality deliverables. Your simple business model, customer-focused and flexible approach to solutions, and deep expertise in the ophthalmology clinical practice make for a seamless experience.

Data scientist principal, pharmaceutical company

Breadth and depth of EHR data

Gain robust insight from expansive and demographically diverse retinal data gathered from:

0 M

Patients

0 M

Patient visits

0 +

Sites

0 +

Retina specialists

0 +

Ophthalmology practitioners

0 +

Experience

Explore the benefits of our retina data

There are times you need a level of detail beyond what is available in most datasets. Access unmatched clinically deep retinal information, such as visual acuity (VA), central retinal thickness (CRT) and retinal fluid, with our retina dataset. With near real-time insights into market trends and changes available, you can be assured you have the most up-to-date data.

Market access and commercial

Reveal broad market insights into the retina landscape at national and regional levels
Highlight longitudinal changes and market shifts
Evaluate the market and competitor landscape
Monitor drug efficacy and durability longitudinally
Arm your teams and colleagues with a strong, clear, easy-to-digest message

Medical affairs and health economics and outcomes research (HEOR)

Answer clinical questions on treatment effectiveness, disease incidence, prevalence and progression
Understand treatment behavior and associated outcomes
Design and develop detailed protocols and statistical analysis plans
Evaluate and assess clinical trial protocols

Clinical operations

Identify the right physicians and patients for clinical trials
Understand impact of specific inclusion and exclusion criteria on recruitment expectations
Search for patients with genetic diseases
Reduce site burden while still ensuring enrollment goals remain on target

Data quality is just the first step. Benefit from in-house availability of experts with extensive knowledge of retinal conditions, treatments and outcomes. We have specialists in areas such as regulatory affairs, health economic modeling, market access and patient-reported outcomes, providing you with high-quality data and exceptional experience in real-world evidence generation. Experience the stability and operational depth of a large-scale company while retaining the responsiveness, attention-to-detail, flexibility and commitment to scientific quality of a smaller specialized company.

From early development through commercialization, our real-world data team empowers you to succeed, with dedicated retinal EMR specialists and a large, diversified group of data scientists with expertise in over 100 data sources across 20 countries.

Clinical trial recruitment acceleration program

Efficiently identifying patients for clinical trials enables you to reduce recruitment times. Our relationship with our panel of health care professionals allows us to analyze their data and identify patients who meet study criteria. Our HIPAA-compliant process allows retina practices to re-identify these patients, and clinical trial staff can contact identified patients for further assessment and enrollment when candidates fit the trial criteria.

Our in-house team of retina specialists, real-world data and proprietary algorithms complement our HCP panel relationship, allowing clients to accelerate enrollment and quickly identify patients who meet study criteria.

With higher levels of patient enrollment, your studies will meet enrollment targets more quickly, and participating retina practices receive the benefit of reduced costs, increased trial revenue and enhanced trial capacity.

The clinical trial recruitment acceleration program is a service for industry-sponsored trials that is available to practices in our retina data panel. In it, our practices can:

Quantify patient recruitment estimates for contract negotiations
Accelerate the patient recruitment process
Replace the need for manual file searches, improving efficiency
Hit trial completion deadlines with faster recruitment
Become a preferred practice-site for trial sponsors
Measure the efficiency of your clinical trial process

corevitas-recruitment-acceleration-program-graphic

I am a big supporter of the retina data team and the value they bring to my clinical studies. Setting expectations and living up to them is one of the most important aspects of running a trial. The trending reports they provide help with accurate forecasting of timelines and the recruitment acceleration program ensures we are setting sites up with every advantage to meet or exceed enrollment goals.

Pharmaceutical clinical trial leader